MacroGenics
MGNX
#9383
Rank
A$0.13 B
Marketcap
A$2.10
Share price
4.89%
Change (1 day)
-61.36%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.40 Billion

According to MacroGenics's latest financial reports the company's total assets are A$0.40 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.42 B-3.96%
2023-12-31A$0.43 B6.28%
2022-12-31A$0.41 B-10.87%
2021-12-31A$0.46 B-6.12%
2020-12-31A$0.49 B10.35%
2019-12-31A$0.44 B-5.33%
2018-12-31A$0.47 B-1.56%
2017-12-31A$0.47 B10.91%
2016-12-31A$0.43 B-12.44%
2015-12-31A$0.49 B132.11%
2014-12-31A$0.21 B50.67%
2013-12-31A$0.14 B172.65%
2012-12-31A$51.71 M-15.4%
2011-12-31A$61.13 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Xencor
XNCR
A$1.30 B 220.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.36 B 76,989.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$195.10 B 47,744.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$88.15 B 21,517.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$135.76 B 33,191.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$173.10 B 42,348.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.92 B 35,683.69%๐Ÿ‡บ๐Ÿ‡ธ USA